Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection.
Crimean-Congo hemorrhagic fever virus
genome-scale metabolic models
post viral fatigue
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
12 09 2023
12 09 2023
Historique:
medline:
7
9
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
ppublish
Résumé
Crimean-Congo hemorrhagic fever (CCHF) caused by CCHF virus (CCHFV) is one of the epidemic-prone diseases prioritized by the World Health Organisation as public health emergency with an urgent need for accelerated research. The trajectory of host response against CCHFV is multifarious and remains unknown. Here, we reported the temporal spectrum of pathogenesis following the CCHFV infection using genome-wide blood transcriptomics analysis followed by advanced systems biology analysis, temporal immune-pathogenic alterations, and context-specific progressive and postinfection genome-scale metabolic models (GSMM) on samples collected during the acute (T0), early convalescent (T1), and convalescent-phase (T2). The interplay between the retinoic acid-inducible gene-I-like/nucleotide-binding oligomerization domain-like receptor and tumor necrosis factor signaling governed the trajectory of antiviral immune responses. The rearrangement of intracellular metabolic fluxes toward the amino acid metabolism and metabolic shift toward oxidative phosphorylation and fatty acid oxidation during acute CCHFV infection determine the pathogenicity. The upregulation of the tricarboxylic acid cycle during CCHFV infection, compared to the noninfected healthy control and between the severity groups, indicated an increased energy demand and cellular stress. The upregulation of glycolysis and pyruvate metabolism potentiated energy generation through alternative pathways associated with the severity of the infection. The downregulation of metabolic processes at the convalescent phase identified by blood cell transcriptomics and single-cell type proteomics of five immune cells (CD4
Identifiants
pubmed: 37669378
doi: 10.1073/pnas.2304722120
pmc: PMC10500270
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2304722120Références
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):395-404
pubmed: 19027345
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nat Biotechnol. 2020 Mar;38(3):276-278
pubmed: 32055031
Genome Biol. 2017 Jan 19;18(1):4
pubmed: 28100256
J Virol. 2018 Oct 12;92(21):
pubmed: 30111561
J Virol. 2016 Dec 16;91(1):
pubmed: 27795421
Arch Pathol Lab Med. 1997 Aug;121(8):839-46
pubmed: 9278612
Front Pediatr. 2018 Dec 04;6:373
pubmed: 30564562
Nucleic Acids Res. 2013 Apr;41(8):4378-91
pubmed: 23444143
Life Sci Alliance. 2022 May 10;5(9):
pubmed: 35537851
Mol Syst Biol. 2014 Mar 19;10:721
pubmed: 24646661
Sci Signal. 2020 Mar 24;13(624):
pubmed: 32209698
Elife. 2022 Apr 19;11:
pubmed: 35437144
Lancet Infect Dis. 2006 Apr;6(4):203-14
pubmed: 16554245
Front Immunol. 2020 May 22;11:1013
pubmed: 32670270
PLoS Comput Biol. 2012;8(5):e1002518
pubmed: 22615553
Elife. 2022 Mar 23;11:
pubmed: 35318939
Emerg Microbes Infect. 2020 Dec;9(1):1748-1760
pubmed: 32691695
Genome Biol. 2014;15(12):550
pubmed: 25516281
Methods Mol Biol. 2020;2120:233-248
pubmed: 32124324
Adv Clin Chem. 2014;66:121-72
pubmed: 25344988
Virol Sin. 2023 Feb;38(1):34-46
pubmed: 36075566
Commun Biol. 2022 Apr 13;5(1):357
pubmed: 35418589
J Gen Virol. 2010 Jan;91(Pt 1):189-98
pubmed: 19812268
Clin Vaccine Immunol. 2010 Jul;17(7):1086-93
pubmed: 20484568
Viruses. 2021 Apr 28;13(5):
pubmed: 33925004
Cell Syst. 2022 Aug 17;13(8):665-681.e4
pubmed: 35933992
Int J Infect Dis. 2009 May;13(3):380-6
pubmed: 18986819
Emerg Infect Dis. 2016 Apr;22(4):641-6
pubmed: 26983037
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
PLoS Pathog. 2022 May 19;18(5):e1010485
pubmed: 35587473
PLoS Comput Biol. 2018 Oct 18;14(10):e1006541
pubmed: 30335785
J Med Virol. 2008 Aug;80(8):1397-404
pubmed: 18551619
Immunity. 2017 Oct 17;47(4):648-663.e8
pubmed: 29045899
Anal Chem. 2022 Jul 5;94(26):9261-9269
pubmed: 35731985
J Virol. 2015 Oct;89(20):10219-29
pubmed: 26223644
Ann Med Surg (Lond). 2022 Aug;80:104273
pubmed: 35936566
PLoS Negl Trop Dis. 2022 Aug 18;16(8):e0010724
pubmed: 35981059
Allergy. 2022 May;77(5):1623-1625
pubmed: 35150456
Sci Rep. 2021 Oct 6;11(1):19807
pubmed: 34615921
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Cell Rep. 2017 Sep 5;20(10):2396-2407
pubmed: 28877473
Clin Microbiol Infect. 2019 Apr;21S:e28-e31
pubmed: 24816494
Antiviral Res. 2013 May;98(2):248-60
pubmed: 23458713
J Infect Dis. 2013 Jun 15;207(12):1909-21
pubmed: 23417661
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Viral Immunol. 2014 Sep;27(7):327-33
pubmed: 25062274
Sci Rep. 2019 Jan 18;9(1):213
pubmed: 30659199
HRB Open Res. 2022 Apr 22;5:31
pubmed: 36101871
Immunol Res. 2002;26(1-3):95-105
pubmed: 12403349